Mouse models of tumor development in neurofibromatosis type 1

被引:335
作者
Cichowski, K
Shih, TS
Schmitt, E
Santiago, S
Reilly, K
McLaughlin, ME
Bronson, RT
Jacks, T
机构
[1] MIT, Dept Biol, Cambridge, MA 02139 USA
[2] MIT, Ctr Canc Res, Cambridge, MA 02139 USA
[3] MIT, Howard Hughes Med Inst, Cambridge, MA 02139 USA
[4] Merck & Co Inc, Whitehouse Stn, NJ 08889 USA
[5] Baylor Coll Med, Breast Ctr, Houston, TX 77030 USA
[6] Brigham & Womens Hosp, Dept Pathol, Boston, MA 02115 USA
[7] Tufts Univ, Sch Med, Dept Pathol, Boston, MA 02111 USA
[8] Tufts Univ, Sch Vet Med, Boston, MA 02111 USA
关键词
D O I
10.1126/science.286.5447.2172
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Neurofibromatosis type 1 (NF1) is a prevalent familiar cancer syndrome resulting from germ Line mutations in the NF1 tumor suppressor gene. Hallmark features of the disease are the development of benign peripheral nerve sheath tumors (neurofibromas), which can progress to malignancy. Unlike humans, mice that are heterozygous for a mutation in Nf1 do not develop neurofibromas. However, as described here, chimeric mice composed in part of Nf1(-/-) cells do, which demonstrates that loss of the wild-type Nf1 allele is rate-limiting in tumor formation. In addition, mice that carry Linked germ line mutations in Nf1 and p53 develop malignant peripheral nerve sheath tumors (MPNSTs), which supports a cooperative and causal role for p53 mutations in MPNST development. These two mouse models provide the means to address fundamental aspects of disease development and to test: therapeutic strategies.
引用
收藏
页码:2172 / 2176
页数:5
相关论文
共 42 条
  • [1] Growth rate characteristics of acoustic neuromas associated with neurofibromatosis type 2
    Abaza, MM
    Makariou, E
    Armstrong, M
    Lalwani, AK
    [J]. LARYNGOSCOPE, 1996, 106 (06) : 694 - 699
  • [2] NEUROFIBROMATOSIS AND CANCER
    BADER, JL
    [J]. ANNALS OF THE NEW YORK ACADEMY OF SCIENCES, 1986, 486 : 57 - 65
  • [3] ABERRANT REGULATION OF RAS PROTEINS IN MALIGNANT-TUMOR CELLS FROM TYPE-1 NEUROFIBROMATOSIS PATIENTS
    BASU, TN
    GUTMANN, DH
    FLETCHER, JA
    GLOVER, TW
    COLLINS, FS
    DOWNWARD, J
    [J]. NATURE, 1992, 356 (6371) : 713 - 715
  • [4] Loss of NF1 results in activation of the Ras signaling pathway and leads to aberrant growth in haematopoietic cells
    Bollag, G
    Clapp, DW
    Shih, S
    Adler, F
    Zhang, YY
    Thompson, P
    Lange, BJ
    Freedman, MH
    McCormick, F
    Jacks, T
    Shannon, K
    [J]. NATURE GENETICS, 1996, 12 (02) : 144 - 148
  • [5] TARGETED DISRUPTION OF THE NEUROFIBROMATOSIS TYPE-1 GENE LEADS TO DEVELOPMENTAL ABNORMALITIES IN HEART AND VARIOUS NEURAL CREST-DERIVED TISSUES
    BRANNAN, CI
    PERKINS, AS
    VOGEL, KS
    RATNER, N
    NORDLUND, ML
    REID, SW
    BUCHBERG, AM
    JENKINS, NA
    PARADA, LF
    COPELAND, NG
    [J]. GENES & DEVELOPMENT, 1994, 8 (09) : 1019 - 1029
  • [6] MOUSE CHROMOSOME-11
    BUCHBERG, AM
    BUCKWALTER, MS
    CAMPER, SA
    [J]. MAMMALIAN GENOME, 1992, 3 : S162 - S181
  • [7] A MAJOR SEGMENT OF THE NEUROFIBROMATOSIS TYPE-1 GENE - CDNA SEQUENCE, GENOMIC STRUCTURE, AND POINT MUTATIONS
    CAWTHON, RM
    WEISS, R
    XU, GF
    VISKOCHIL, D
    CULVER, M
    STEVENS, J
    ROBERTSON, M
    DUNN, D
    GESTELAND, R
    OCONNELL, P
    WHITE, R
    [J]. CELL, 1990, 62 (01) : 193 - 201
  • [8] BENIGN NEUROFIBROMAS IN TYPE-1 NEUROFIBROMATOSIS (NF1) SHOW SOMATIC DELETIONS OF THE NF1 GENE
    COLMAN, SD
    WILLIAMS, CA
    WALLACE, MR
    [J]. NATURE GENETICS, 1995, 11 (01) : 90 - 92
  • [9] Clonal origin of tumor cells in a plexiform neurofibroma with LOH in NF1 intron 38 and in dermal neurofibromas without LOH of the NF1 gene
    Daschner, K
    Assum, G
    Eisenbarth, I
    Krone, W
    Hoffmeyer, S
    Wortmann, S
    Heymer, B
    KehrerSawatzki, H
    [J]. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1997, 234 (02) : 346 - 350
  • [10] ABNORMAL REGULATION OF MAMMALIAN P21(RAS) CONTRIBUTES TO MALIGNANT-TUMOR GROWTH IN VONRECKLINGHAUSEN (TYPE-1) NEUROFIBROMATOSIS
    DECLUE, JE
    PAPAGEORGE, AG
    FLETCHER, JA
    DIEHL, SR
    RATNER, N
    VASS, WC
    LOWY, DR
    [J]. CELL, 1992, 69 (02) : 265 - 273